CME in Minutes: Education in Primary Care

John O. Mascarenhas, MD - Optimizing JAK Inhibitor Therapy for Patients With Myelofibrosis: Integrating New and Emerging Therapies Into the Current Treatment Paradigm


Listen Later

Please visit answersincme.com/BCJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hematology discusses JAK inhibitor therapy for patients with myelofibrosis. Upon completion of this activity, participants should be better able to: Identify early signs of ruxolitinib failure for timely risk stratification of patients with myelofibrosis (MF); Describe the clinical profiles of novel JAK inhibitors for the treatment of patients with MF; and Outline evidence-based strategies to optimize JAK inhibitor therapy for patients with MF.
...more
View all episodesView all episodes
Download on the App Store

CME in Minutes: Education in Primary CareBy Answers in CME

  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

5 ratings


More shows like CME in Minutes: Education in Primary Care

View all
CME in Minutes: Education in Cardiology & Pulmonology by Answers in CME

CME in Minutes: Education in Cardiology & Pulmonology

3 Listeners

CME in Minutes: Education in Oncology & Hematology by Answers in CME

CME in Minutes: Education in Oncology & Hematology

5 Listeners

CME in Minutes: Education in Dermatology by Answers in CME

CME in Minutes: Education in Dermatology

3 Listeners

CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases by Answers in CME

CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases

4 Listeners

CME in Minutes: Education in Ophthalmology by Answers in CME

CME in Minutes: Education in Ophthalmology

0 Listeners